login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CUMBERLAND PHARMACEUTICALS (CPIX) Stock News
USA
- NASDAQ:CPIX -
US2307701092
-
Common Stock
2.13
USD
-0.06 (-2.74%)
Last: 11/7/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CPIX Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Cumberland Pharmaceuticals Inc.
CUMBERLAND PHARMACEUTICALS REPORTS 12% YEAR-TO-DATE REVENUE GROWTH
4 days ago - By: Benzinga
- Mentions:
KURA
SEE
HRMY
FOLD
...
Earnings Scheduled For November 4, 2025
11 days ago - By: Cumberland Pharmaceuticals Inc.
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE
19 days ago - By: Cumberland Pharmaceuticals Inc.
- Mentions:
RDHL
CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO
26 days ago - By: Cumberland Pharmaceuticals Inc.
CUMBERLAND PHARMACEUTICALS' VIBATIV® ADDED TO NATIONAL GROUP PURCHASING AGREEMENT WITH PREMIER, INC.
a month ago - By: Cumberland Pharmaceuticals Inc.
CUMBERLAND PHARMACEUTICALS ANNOUNCES PRODUCT APPROVAL IN MEXICO
3 months ago - By: Benzinga
- Mentions:
AFG
CXDO
YUM
PACK
...
Earnings Scheduled For August 5, 2025
a month ago - By: Cumberland Pharmaceuticals Inc.
TABUK LAUNCHES VIBATIV® FDA-APPROVED ANTIBIOTIC WITH LIFE-SAVING POTENTIAL IN SAUDI ARABIA
3 months ago - By: The Motley Fool
Cumberland (CPIX) Q2 Revenue Up 10%
3 months ago - By: Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Reports 23% Revenue Growth Year-to-Date
3 months ago - By: Cumberland Pharmaceuticals Inc.
CUMBERLAND PHARMACEUTICALS RECEIVES VIZIENT CONTRACT FOR NEW VIBATIV® 4-VIAL STARTER PAK
3 months ago - By: Cumberland Pharmaceuticals Inc.
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q2 2025 FINANCIAL RESULTS & COMPANY UPDATE
5 months ago - By: Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Shares Phase 2 FIGHT DMD Trial Results at the Parent Project Muscular Dystrophy Annual Conference
5 months ago - By: Cumberland Pharmaceuticals Inc.
NEW STUDY FINDS CALDOLOR® SAFE AND EFFECTIVE FOR OPIOID-SPARING PAIN MANAGEMENT IN OLDER ADULTS
6 months ago - By: Cumberland Pharmaceuticals Inc.
CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH
6 months ago - By: Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025
6 months ago - By: Cumberland Pharmaceuticals Inc.
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2025 FINANCIAL RESULTS & COMPANY UPDATE
8 months ago - By: Cumberland Pharmaceuticals Inc.
FIGHT DMD Trial Results Selected for Late-Breaking Presentation at MDA Clinical & Scientific Conference
8 months ago - By: Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Reports 11.6% Fourth Quarter 2024 Revenue Growth
9 months ago - By: Cumberland Pharmaceuticals Inc.
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2024 FINANCIAL RESULTS
9 months ago - By: Cumberland Pharmaceuticals Inc.
VIBATIV® RECEIVES MARKETING APPROVAL IN CHINA
9 months ago - By: Cumberland Pharmaceuticals Inc.
Cumberland Pharmaceuticals Announces Breakthrough Results from the Phase 2 FIGHT DMD Trial in Duchenne Muscular Dystrophy Heart Disease
a year ago - By: Yahoo Finance
Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday?
Please enable JavaScript to continue using this application.